Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

Healing of non-displaced fractures produced by fatigue loading of the mouse ulna

(2010) Mario D. Martinez et al.   BONE

Atypical fractures of the femur and bisphosphonate therapy

(2010) Andrea Giusti et al.   BONE

Femoral Cortical Stress Lesions in Long-Term Bisphosphonate Therapy: A Herald of Impending Fracture?

(2010) Joyce S B Koh et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-Energy Femoral Fractures Associated With Long-Term Bisphosphonate Use in a Rehabilitation Setting: A Case Series

(2010) Robert D. Bunning et al.   PM&R

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

(2009) Jörg Schilcher et al.   Acta Orthopaedica

Spontaneous femoral shaft fracture after long-term alendronate

(2009) T. Ali et al.   AGE AND AGEING

Subtrochanteric stress fractures in six patients on long term bisphosphonate therapy: A case series

(2009) D.A. Glennon   BONE

Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series

(2009) Reina Armamento-Villareal et al.   CALCIFIED TISSUE INTERNATIONAL

Unusual mid-shaft fractures during long-term bisphosphonate therapy

(2009) Clarita V. Odvina et al.   CLINICAL ENDOCRINOLOGY

Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy

(2009) Katerina Cermak et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy

(2009) Arkan S. Sayed-Noor et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates

(2009) Kuntheavy Ing-Lorenzini et al.   DRUG SAFETY

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium

(2009) Joon Kiong LEE   International Journal of Rheumatic Diseases

Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy

(2009) Craig M. Capeci et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Bilateral Fractures of the Femur Diaphysis in a Patient With Rheumatoid Arthritis on Long-Term Treatment With Alendronate: Clues to the Mechanism of Increased Bone Fragility

(2009) Matthijs P Somford et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

(2009) David M Reid et al.   LANCET

Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use

(2009) Maria S. Goddard et al.   ORTHOPEDICS

Alendronate-related femoral diaphysis fracture—what should be done to predict and prevent subsequent fracture of the contralateral side?

(2009) M. H. Edwards et al.   OSTEOPOROSIS INTERNATIONAL

Fragility fractures of the hip and femur: incidence and patient characteristics

(2009) J. W. Nieves et al.   OSTEOPOROSIS INTERNATIONAL

Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case report

(2008) Arkan S Sayed-Noor et al.   Acta Orthopaedica

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

(2008) René Rizzoli et al.   BONE

Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss

(2008) Michael R. McClung et al.   BONE

Alendronate Reduces Bone Toughness of Ribs without Significantly Increasing Microdamage Accumulation in Dogs Following 3 Years of Daily Treatment

(2008) Matthew R. Allen et al.   CALCIFIED TISSUE INTERNATIONAL

Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension

(2008) Jacob A. Stakkestad et al.   CLINICAL RHEUMATOLOGY

An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?

(2008) Ernest Beng Kee Kwek et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study

(2008) Bo Abrahamsen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Severely Suppressed Bone Turnover and Atypical Skeletal Fragility

(2008) Maja Visekruna et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low-Energy Femoral Shaft Fractures Associated With Alendronate Use

(2008) Andrew S Neviaser et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

More on Atypical Fractures of the Femoral Diaphysis

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate

(2008) Brett A. Lenart et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

(2008) B. A. Lenart et al.   OSTEOPOROSIS INTERNATIONAL

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

(2008) A. L. Boskey et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL